December 2020 in “Journal of The American Academy of Dermatology” Artificial intelligence can accurately predict hair growth and treatment results in female pattern hair loss patients, with age of onset and duration being key factors.
April 2022 in “Research Square (Research Square)” This study surveyed 286 patients with long COVID to analyze clinical features, recovery periods, and factors affecting recovery. Common symptoms included respiratory issues and fatigue, with hair loss emerging as a significant late-phase complaint and showing the worst treatment outcomes. Smoking was identified as an independent risk factor for prolonged recovery, while factors like sex, age, and comorbidities were not. The study proposed therapeutic options, including inhaled budesonide and herbal medications, but noted limitations such as a small sample size and lack of data on the Omicron variant and vaccination effects. The study emphasized the need for early intervention, smoking cessation, and further research to understand long COVID, treating it as a distinct disease from the common cold or flu.
April 2023 in “Journal of Investigative Dermatology” Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.
Cord blood platelets may have promising future medical uses but need more research.
January 2019 in “Springer eBooks” Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.